Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies.
Clicks: 455
ID: 1512
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
72.3
/100
455 views
307 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #1 of 236 articles by views in chirality
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 236 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In this study, a series of fluorine-containing chiral hydrazide-hydrazone derivatives [III-XII] from ʟ-cysteine ethyl ester hydrochloride was synthesized as new antioxidant and anticholinesterase agents. The antioxidant activity of these derivatives was evaluated by ABTS and DPPH scavenging and CUPRAC assays and the anticholinesterase activity by the Ellman method spectrophotometrically. The results of the antioxidant assay showed that compounds V, IX, and X exhibited higher activity than BHT and α-tocopherol used as positive standards. Among the synthesized derivatives, compound IX (IC : 2.3 ± 1.6 μM) exhibited higher acetylcholinesterase inhibitory activity than galantamine (IC : 4.5 ± 0.8 μM). Compounds XI (IC : 9.6 ± 1.0 μM), IX (IC : 12.5 ± 1.6 μM), III (IC : 16.0 ± 1.6 μM), X (IC : 17.2 ± 1.8 μM), VI (IC : 20.2 ± 0.8 μM), XII (IC : 21.5 ± 1.0 μM), and VII (IC : 24.6 ± 0.6 μM) displayed better butyrylcholinesterase inhibitory activity than galantamine (IC : 46.03 ± 0.14 μM). ADME-Tox analysis was used to probe the drug-like properties of the compounds. Molecular docking studies were also applied to understand the interactions between compounds and targets. The docking calculations were supported by the experimental data. In particular, compound IX, having better activity than galantamine against acetylcholinesterase and butyrylcholinesterase enzymes, was visualized using molecular docking.
| Reference Key |
sıcak2019novel
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sıcak, Yusuf;Oruç-Emre, Emine Elçin;Öztürk, Mehmet;Taşkın-Tok, Tuğba;Karaküçük-Iyidoğan, Ayşegül; |
| Journal | chirality |
| Year | 2019 |
| DOI |
10.1002/chir.23102
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.